The Beachbody Company account plan
Digital fitness subscription service
At a glance
The Beachbody Company (BODi) sells fitness streaming and nutrition products such as Shakeology and P90X; FY2025 revenue was $251.7 million.
The Beachbody Company, trading as BODi, is a US fitness and nutrition company: it runs the BODi streaming platform (over 140 complete programs and brands such as P90X, Insanity and 21 Day Fix) and sells nutritional products led by Shakeology. After replacing its multi-level marketing network with a single-level affiliate model in late 2024, it sells direct to consumers, on Amazon, through affiliates and, since 2026, in retail stores. FY2025 revenue was $251.7 million, down 40%, with operating income of $5.5 million, its first full-year operating income since going public in 2021, and a net loss of $2.9 million. It had about 270 full-time employees at the end of 2025, is remote-first and asset-light, and United States revenue was $232.6 million. Co-founder and CEO Carl Daikeler controls over 80% of the voting power; Mark Goldston is Executive Chairman.
Business units
Digital
about 61% of FY2025 revenue ($153.3 million)BODi streaming subscriptions (annual subscription $179) and one-off digital program purchases. Revenue fell 32% in 2025 as average subscriptions dropped, and digital subscriptions fell to 0.69 million at Q3 2026; the gross margin is high, at 86.3% in Q3 2026.
Nutrition and other
about 39% of FY2025 revenue ($97.6 million)Shakeology, Beachbody Performance supplements, the P90X nutrition line and energy drinks, sold by subscription, one-time orders, Amazon and now retail. Revenue fell 48% in 2025 and the gross margin was 45.8% in Q3 2026 on heavier promotions; it is now the focus of the nutrition-first strategy.
Connected fitness (discontinued)
about 0.3% of FY2025 revenue ($0.9 million)The BODi Bike and connected equipment from the 2021 Myx Fitness acquisition; sales stopped in Q1 2025.
Strategic priorities
- Nutrition-first, multi-channel
- Customer acquisition now leads with nutrition, especially Shakeology, targeting a nutritional supplement category of about $164 billion against about $13 billion for digital fitness; the revenue mix of about 64% digital and 36% nutrition should move toward 50/50.
- Retail expansion
- Shakeology entered retail for the first time in 2026 and is in 181 Sprouts stores and 481 Vitamin Shoppe stores, with KeHE as a path to grocery and energy drinks in a Southern California test market.
- New products
- A P90X performance nutrition line, P90X and INSANITY Liquid Shock energy drinks, seven-serve Shakeology, 10-Minute BODi and a BODi 365 program for 2027.
- Win back former customers
- A CRM base of over 10 million former customers is targeted with email, SMS and paid social through Bloomreach, plus a creator army of affiliates and influencers and SEO and GEO work.
- Lower break-even
- The October 2026 restructuring cut the cost base by more than $30 million and brings the adjusted EBITDA break-even to about $125 million.
Latest results
In Q3 2026 (three months to September 30, 2026) revenue fell 25% to $45.2 million: Digital $27.8 million (-24%) and Nutrition and other $17.4 million (-26%). The gross margin fell to 70.7% from 74.6% on heavier nutrition promotions, while operating income was $1.3 million and net income $3.3 million, the fifth consecutive profitable quarter; Adjusted EBITDA was $6.4 million. Digital subscriptions fell to 0.69 million and cash to $27.5 million. Q4 2026 guidance is revenue of $38-42 million and Adjusted EBITDA of $6-9 million.
Investments and deals
- Nutrition Restructuring
- On October 6, 2026 about 80 employees (about 31% of the workforce) were cut, costing about $3.0 million in Q4 2026; the CFO puts 2027 savings at about $34 million.
- Turnkey manufacturing
- Supplement manufacturing moves to co-manufacturers so about $8 million of raw materials leaves the books over time.
- ABL Facility
- A $35.0 million ABL Facility from Tiger Finance (SOFR plus 9.00%, maturing May 13, 2028) replaced the Blue Torch Term Loan in May 2025; Amendment No. 2 in August 2026 limited covenant testing to cash below $22.5 million.
- Marketing stack
- A Shopify storefront and Bloomreach installed for CRM, segmentation and lifecycle communications.
Challenges and risks
- Subscriber attrition
- Digital subscriptions fell from 0.90 million to 0.69 million in a year; the Executive Chairman says "our rate of attrition has exceeded our rate of addition."
- Retail timing
- Shelf space depends on planogram reset cycles, mostly in the spring, and the growth turnaround is taking longer than expected largely because of retail timing.
- Dependence on Shakeology
- The 10-K states that a substantial portion of revenue comes from the Shakeology line, and nutrition margins fell on promotions.
- Shrinking cash and covenants
- Cash fell to $27.5 million and the net cash position to $4.6 million at September 30, 2026, with nine-month free cash flow of -$12.1 million and ABL covenants to meet.
- GLP-1 drugs and competition
- GLP-1 weight-loss drugs, at-home fitness apps and supplement companies compete in a fragmented market.
What leadership says
“The nutritional supplement category is about $164 billion. Compare that with about $13 billion for the digital fitness category.”
“The timing is what the timing is, and it's outside of our control.”
“the number one risk of a GLP-1 drug is the loss of lean muscle mass”
Where a supplier can help
- Retail and grocery distribution
- The retail expansion through Sprouts, Vitamin Shoppe, KeHE and an energy-drink test market creates needs for trade marketing, merchandising and retail analytics partners.
- Customer win-back and lifecycle marketing
- Winning back over 10 million former customers through Bloomreach, email, SMS and paid social fits lifecycle marketing, data and creative services.
- Creator and AI search acquisition
- The creator army of affiliates and influencers, TikTok shops and SEO and GEO work suit influencer platforms and AI search visibility vendors.
- Co-manufacturing and supply chain
- The move to turnkey co-manufacturing and new product lines opens doors for supplement manufacturers, packaging and logistics providers.
- Cost efficiency
- With a lower break-even target and shrinking cash, BODi favours suppliers that cut cost or are priced on results.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like The Beachbody Company?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Form 10-K for the fiscal year ended December 31, 2025
- The Beachbody Company (BODi) is a fitness and nutrition company: the BODi streaming platform (over 140 complete programs, over 11,000 unique videos; brands P90X, Insanity, 21 Day Fix, LIIFT4) plus nutritional products (Shakeology, Beachbody Performance).
- FY2025 revenue was $251.7 million, a 40% decrease; Digital $153.3 million (-32%), Nutrition and other $97.6 million (-48%), Connected fitness $0.9 million (-87%, bike sales ceased in Q1 2025).
- First full-year operating income since going public in 2021: $5.5 million (vs. an operating loss of $66.2 million); net loss $2.9 million; Adjusted EBITDA $30.8 million; gross margin 73.0% (+440 bps).
- The Pivot (announced September 30, 2024) replaced the MLM Partner network with a single-level affiliate model from November 1, 2024, centralised sales on BODi.com and cut the workforce by about 33%; Partner compensation fell from $119.3 million to $26.3 million.
- Digital subscriptions fell to 0.87 million (from 1.07 million) and nutritional subscriptions to 0.08 million; average digital retention 96.9%, DAU/MAU 31.8%.
- 2026 plan: a retail initiative selling Shakeology in stores for the first time in H1 2026, followed by a new P90X nutritional line and Insanity-branded supplements.
- Asset-light: contract manufacturers and third-party logistics (Walton, Kentucky); about 270 full-time employees, remote-first; United States revenue $232.6 million of $251.7 million.
- Balance sheet: cash $39.0 million, net cash position $15.4 million; a $35.0 million ABL Facility with Tiger Finance (SOFR plus 9.00%) replaced the Blue Torch Term Loan in May 2025.
- Co-founder and CEO Carl Daikeler controls over 80% of the voting power through Class X super-voting stock; Mark Goldston is Executive Chairman, Brad Ramberg Interim CFO.
- Key risks: dependence on a few key products (Shakeology), execution of the Pivot, subscriber attrition, GLP-1 weight-loss drugs and competition, ABL covenants.
- Form 10-Q for the quarter ended September 30, 2026
- Q3 2026 (three months to September 30, 2026): revenue $45.2 million, down 25%; Digital $27.8 million (-24%), Nutrition and other $17.4 million (-26%).
- Gross margin 70.7% (-390 bps); Digital gross margin 86.3%, Nutrition and other 45.8% on heavier promotions.
- Operating income $1.3 million and net income $3.3 million, each the fifth consecutive quarter of profit; Adjusted EBITDA $6.4 million (vs. $9.5 million).
- Nine months: revenue $149.1 million (-24%), operating income $6.1 million, net income $7.0 million, Adjusted EBITDA $21.0 million (vs. $17.9 million).
- Digital subscriptions down to 0.69 million (from 0.90 million) and average digital retention 95.4% (from 96.9%); nutritional subscriptions 0.06 million.
- On October 6, 2026 the "Nutrition Restructuring", tied to a shift in focus from digital to nutrition, cut about 80 employees (about 31% of the workforce), costing about $3.0 million in Q4 2026.
- Cash fell to $27.5 million and net cash position to $4.6 million; nine-month free cash flow was -$12.1 million.
- Amendment No. 2 to the ABL Facility (August 3, 2026) set covenant testing only below $22.5 million of cash and kept the rate at SOFR plus 9.00% to maturity.
- BODi Q3 2026 earnings call
- Q3 2026 call (November 10, 2026) with Executive Chairman Mark Goldston, co-founder and CEO Carl Daikeler and CFO Brad Ramberg: revenue $45.2 million, Adjusted EBITDA $6.4 million, the 12th consecutive quarter of positive adjusted EBITDA.
- Goldston: the financial turnaround has gone "better than planned", but the growth turnaround "is taking a little longer than we expected, largely because of retail timing"; attrition from the former MLM base still exceeds new additions.
- The early-October restructuring cut the cost base by more than $30 million; Ramberg puts 2027 savings at about $34 million and the adjusted EBITDA break-even at $125 million, down from $900 million in 2022.
- Strategy is now "nutrition-first, multi-channel": the nutritional supplement category (about $164 billion) is targeted over digital fitness (about $13 billion).
- Retail: Shakeology in 181 Sprouts stores and 481 Vitamin Shoppe stores; KeHE gives a path to grocery; P90X and INSANITY Liquid Shock energy drinks in a Southern California test market with broker L.A. Libations; P90X supplements and seven-serve Shakeology on Amazon.
- Marketing stack: Shopify storefront, Bloomreach installed for CRM, segmentation and lifecycle communications; a "creator army" of affiliates and influencers; SEO and GEO work.
- Operations: supplement manufacturing moves to a turnkey model with co-manufacturers (about $8 million of raw materials on the books).
- Q4 2026 guidance: revenue $38-42 million, Adjusted EBITDA $6-9 million, mix about 64% digital and 36% nutrition; long-term aim of about 50/50.
- BODi at Canaccord Genuity's 46th Annual Growth Conference
- Mark Goldston, Executive Chairman, presenting BODi at Canaccord Genuity's 46th Annual Growth Conference (August 2026), with CFO Brad Ramberg.
- Turnaround claims: headcount down from over 1,000 to under 300, adjusted EBITDA break-even cut from $900 million to $160 million, 11 consecutive quarters of positive adjusted EBITDA totalling $76.5 million.
- Company history: 28 years, over $12.5 billion of cumulative sales, a 2015 peak of $1.2 billion revenue; went public by de-SPAC in 2021 at a $3.2 billion market cap.
- MLM disbanded in December 2024; the company is back to DTC and expanding into brick-and-mortar retail; a Hilco valuation put the fitness library at over $500 million.
- Advertising pivoted to nutrition first because the fitness market is about $13 billion against $164 billion for nutritional supplements.
- Retail: Shakeology (never sold at retail before) in Sprouts (88 then 131 stores) and 481 Vitamin Shoppe stores; seven-serve Shakeology at $34.95 versus a 30-serve $129 bag; P90X supplements at $15 to $39.95.
- Pipeline pulled forward from 2027 into 2026: 10-Minute BODi, a new P90X program, P90X and Insanity energy drinks, Shaun T's MAX BUILT, an Insanity program with Hunter McIntyre.
- Target audiences: 185 million overweight Americans and GLP-1 users who need protein and exercise to keep lean muscle; a CRM base of 10 million+ former customers to win back.
Questions about The Beachbody Company
What does The Beachbody Company do?
BODi sells fitness streaming subscriptions and nutritional products, including Shakeology, P90X nutrition and Insanity-branded products, through its website, Amazon, affiliates and retail stores.
What is The Beachbody Company's revenue?
FY2025 revenue was $251.7 million, down 40%. Nine-month 2026 revenue was $149.1 million, down 24%.
How many employees does The Beachbody Company have?
It had about 270 full-time employees at December 31, 2025, and the October 2026 restructuring cut about 80 more.
What is BODi's strategy?
A nutrition-first, multi-channel strategy that leads with Shakeology and new supplements, expands into retail and keeps digital fitness as a complement.
Who leads The Beachbody Company?
Co-founder Carl Daikeler is CEO, Mark Goldston is Executive Chairman and Brad Ramberg is CFO.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)